- Home
- PHUN vs ORMP Comparison
PHUN vs ORMP Comparison
Compare PHUN & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHUN | ORMP |
|---|---|---|
| Founded | 2009 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.1M | 197.6M |
| IPO Year | 2016 | 2010 |
Fundamental Metrics
Financial Performance| Metric | PHUN | ORMP |
|---|---|---|
| Price | $2.00 | $4.49 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 87.1K | ★ 136.9K |
| Earning Date | 11-05-2026 | 11-12-2026 |
| Dividend Yield | N/A | ★ 5.35% |
| EPS Growth | 39.36 | ★ 412.50 |
| EPS | N/A | ★ 2.76 |
| Revenue | ★ $30,883,000.00 | $2,000,000.00 |
| Revenue This Year | $37.21 | N/A |
| Revenue Next Year | $1,931.97 | N/A |
| P/E Ratio | ★ N/A | $1.70 |
| Revenue Growth | 15.57 | ★ 49.25 |
| 52 Week Low | $1.56 | $2.09 |
| 52 Week High | $3.13 | $5.47 |
Technical Indicators
Market Signals| Indicator | PHUN | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 44.21 | 45.98 |
| Support Level | $1.95 | $4.54 |
| Resistance Level | $2.00 | $5.01 |
| Average True Range (ATR) | 0.04 | 0.13 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 45.45 | 30.56 |
Price Performance
Historical ComparisonAbout PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services. Development services for customers who wish to have a customized application experience; and In-app advertising services for mobile audience building, user acquisition, application discovery, audience engagement and monetization.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.